In Brief
Postsynaptic AMPA receptor exocytosis underlies several forms of excitatory synaptic plasticity. In this study, Arendt et al. demonstrated that distinct SNAREdependent mechanisms are involved in synaptic integration of AMPA receptors during LTP and retinoic acid-mediated homeostatic synaptic plasticity.
INTRODUCTION
The ability of a neuron to change its responsiveness to synaptic inputs based on prior activity and experience is an essential feature of the nervous system. These changes can occur in the properties intrinsic to a neuron (i.e., membrane excitability) or at synapses where communication between two neurons is achieved. Long-term potentiation (LTP) at synapses is thought to underlie modification of neural circuits that drive behaviors, enable learning, and encode memory. The known forms of long-term synaptic plasticity include at least two main categories: Hebbian and homeostatic. Compared to Hebbian plasticity, the mechanisms and functional significance of homeostatic synaptic plasticity are less understood. One of the main open questions is whether and how homeostatic synaptic plasticity intersects with Hebbian synaptic plasticity at the functional and molecular levels. Although operating under different computational rules and likely involving distinct molecular mechanisms, homeostatic synaptic plasticity directly impacts the basal state of synapses and is, therefore, likely to indirectly affect Hebbian plasticity.
We have previously described a critical involvement of retinoic acid (RA) in a form of homeostatic synaptic plasticity that is induced by prolonged reduction in synaptic excitation Chen et al., 2014; Sarti et al., 2013) . Acting through a distinct molecular mechanism, RA is capable of rapidly changing excitatory as well as inhibitory synaptic strength Sarti et al., 2013) . Thus, through its effects on both excitation and inhibition, the synaptic action of RA may impact Hebbian plasticity due to an altered synaptic excitation/inhibition balance. Indeed, vitamin A deficiency (which depletes RA) impairs hippocampal Hebbian plasticity and learning (Chiang et al., 1998; Cocco et al., 2002; Misner et al., 2001 ). Moreover, a study using a dominant-negative form of RARa expressed in adult forebrain demonstrated impairments in AMPA receptor (AMPAR)-mediated synaptic transmission, hippocampal LTP, hippocampal-dependent social recognition, and spatial memory (Nomoto et al., 2012) . However, how RA-induced increases in excitatory synaptic transmission affect Hebbian plasticity has not been investigated.
At the molecular level, changes in synaptic AMPAR abundance have been described for both RA-induced and Hebbian plasticity (e.g., postsynaptic NMDA receptor [NMDAR]-dependent LTP). The molecular machinery that governs AMPAR exocytosis is just beginning to be uncovered. Similar to presynaptic-activity-dependent vesicle exocytosis (i.e., calcium-triggered neurotransmitter release) (Sü dhof and Rothman, 2009) , postsynaptic AMPAR exocytosis during LTP requires a SNARE (soluble NSF-attachment protein receptor)-dependent membrane-fusion machinery (Ahmad et al., 2012; Jurado et al., 2013) . Specifically, both processes require the R-SNARE synaptobrevin-2 (Syb-2) and the SNARE-activating molecule complexin (Cpx) but differ in the QSNAREs. Whereas calcium-triggered synaptic vesicle exocytosis requires the Q-SNAREs SNAP-25 and syntaxin-1 (Stx-1), LTPinduced AMPAR exocytosis requires SNAP-47 and syntaxin-3 (Stx-3) (Jurado et al., 2013) . Thus, questions arise regarding whether the complex formed by Syb-2, Stx-3, SNAP-47, and Cpx represents a SNARE machinery universally used for all forms of postsynaptic-activity-dependent AMPAR exocytosis and whether the similarity and/or differences in the molecular composition of the AMPAR exocytosis machinery between Hebbian and RA-induced plasticity accounts for a possible functional impact of synaptic RA signaling on Hebbian plasticity.
In the present study, we examined the impact of RA on Hebbian plasticity in the hippocampus. We found that acute RA treatment impairs subsequent expression of LTP and that this impairment can be reversed by acute genetic deletion of RARa or by inhibiting protein synthesis during RA treatment. Unexpectedly, we found that, similar to what occurs during LTP, synaptic incorporation of AMPARs by RA requires synaptic activity and NMDAR activation. Thus, we examined the potential convergence of the molecular mechanisms underlying the activitydependent AMPAR insertion between LTP and RA-induced AMPAR exocytosis. Using a short hairpin RNA (shRNA)-based approach, we found that RA-and LTP-induced AMPAR insertions are both regulated by activity and that both require some of the same SNARE proteins, such as SNAP-47 and Syb-2, but differ in two important components of the SNARE membranefusion machinery. First, although Cpx is required for LTP, it does not play a role in RA-induced AMPAR exocytosis. Second, whereas Stx-3 (which interacts with Cpx) is required for LTP, Stx-4 (which does not bind Cpx) is required for RA-induced AMPAR exocytosis. Thus, our findings reveal a previously unidentified, activity-dependent AMPAR exocytosis pathway, which utilizes a unique vesicle fusion machinery that is distinct from that used during LTP or during constitutive AMPAR exocytosis at synapses.
RESULTS

Synaptic RA Signaling Blocks LTP Expression
To directly investigate the impact of synaptic RA signaling on hippocampal LTP, we examined LTP induction at Schaffer collateral-CA1 synapses after acute RA treatment (2-4 hr) in organotypic cultured hippocampal slices. Using a classical pairing protocol, we reliably induced LTP in DMSO-treated slices but not in RA-treated slices ( Figure 1A ; Figure S1A ) (DMSO, 269.91% ± 31.57%; RA, 113.37% ± 7.68%; measured 55-60 min after induction). Given the previously established role of RARa in synaptic RA signaling Poon and Chen, 2008) , we asked whether this RA blockade of LTP is also mediated by RARa. We injected lentiviruses expressing either wild-type (active) or mutant (inactive) Cre recombinase (Cre or mCre, respectively) into the CA1 pyramidal cell layer of cultured slices obtained from conditional RARa KO mice (Chapellier et al., 2002; Sarti et al., 2012) , thus selectively deleting RARa in postsynaptic neurons. Deletion of RARa did not impair LTP (Figures 1B and S1B) (mCre/DMSO, 308.77% ± 27.22%; Cre/DMSO, 261.34% ± 24.2%), consistent with previous observations that RA/RARa signaling is specifically involved in homeostatic synaptic plasticity but not LTP Sarti et al., 2012) . RA treatment in mCre-infected neurons, similar to that in uninfected neurons, greatly diminished LTP (Figures 1B and S1B) (mCre/ RA, 152.22% ± 27.22%), whereas deletion of RARa rescued the ability of neurons to undergo LTP following RA treatment (Figures 1B and S1B) (Cre/RA, 322.67% ± 73.21%). Thus, although RA/RARa signaling is not required for LTP, RA's action on excitatory synapses prevents subsequent induction of LTP, and this effect of RA operates by an RARa-mediated signaling pathway.
RA is traditionally considered a key transcription factor during development (Maden, 2007) , but it also controls synaptic strength by regulating local protein synthesis in neuronal dendrites (Maghsoodi et al., 2008; Poon and Chen, 2008) . To test whether RA blocks LTP induction through an action that also requires protein synthesis, we examined the effect of a protein synthesis blocker, anisomycin, on LTP. Pretreating slices with anisomycin for 2 hr (which blocks the effect of RA on synaptic strength; Aoto et al., 2008) rescued LTP in RA-treated slices (Figures 1C and S1C) (RA, 129.52% ± 12.62%; anisomycin + RA, 217.22% ± 21.42%), confirming the hypothesis that RA blocks LTP via a protein synthesis-dependent process. Anisomycin treatment, however, did not affect LTP under control conditions, demonstrating that its effect is specific to the RA condition (Figures 1C and S1C) (anisomycin, 225 .30% ± 21.99%; measured 55-60 min after induction). To further control for potential nonspecific effects of anisomycin, we repeated the same series of experiments with another protein synthesis inhibitor, cycloheximide. Similar to anisomycin, cycloheximde co-treated with RA blocked the effect of RA on LTP (Figures S1D and S1E) (RA, 110.70% ± 7.21%; cycloheximide, 242.53% ± 23.12%; cycloheximide + RA, 198.75% ± 17.50%).
RA-Induced AMPAR Insertion Is Activity Dependent
One interpretation for the impaired LTP after RA treatment is that RA increases excitatory synaptic strength and thereby prevents the subsequent potentiation of synapses evoked by LTP-induction protocols. Therefore, we wanted to first confirm that RA, indeed, increased synaptic excitation under our experimental conditions. Consistent with previous results , RA increased the amplitude, but not the frequency, of miniature excitatory postsynaptic currents (mEPSCs) from hippocampal CA1 neurons (Figure 2A ) (DMSO, 12.85 ± 0.33 pA, 0.78 ± 0.12 Hz; RA, 15.10 ± 0.48 pA, 0.70 ± 0.09 Hz) . We previously reported that RA potentiates the mEPSC amplitude of primary cultured neurons in a multiplicative fashion , similar to synaptic scaling in response to activity blockade (Turrigiano et al., 1998) . We wondered whether RA-induced potentiation of mEPSC in organotypic slices follows the same pattern. When ranked mEPSC amplitudes of RA-treated responses were plotted against those of DMSO-treated responses, we noticed that, for more than 95% of mEPSCs that exhibit mEPSC amplitudes of <30 pA, the increase in mEPSC amplitude appeared to be strictly multiplicative (i.e., scaled; Figure S2A1 ). However, at large mEPSC amplitudes (30-60 pA, less than 5% of the total population), supralinear and sublinear potentiation was observed ( Figure S2A2 ). Thus, RA-mediated potentiation primarily follows a multiplicative pattern for the majority of mEPSCs. The complexity of the potentiation pattern associated with a small subset of responses at higher amplitudes may reflect RA's heterogeneous action at a subset of synapses. We speculate that the differences in pathway/input type and the states of the synapses, which are better preserved in organotypic slices, may underlie such complexity.
To test whether RA enhances both AMPAR-mediated and NMDAR-mediated components of excitatory synaptic trans- mission, we recorded dual-component mEPSCs in the absence of external Mg 2+ (Arendt et al., 2013) . RA treatment did not result in any significant increase in the NMDAR-mediated component of mEPSCs (DMSO, 2.03 ± 0.22 pA; RA, 2.38 ± 0.20 pA), despite the persistent increase in the AMPAR-mediated component as measured in this analysis (DMSO, 10.56 ± 0.39 pA; RA, 12.33 ± 0.59 pA) ( Figure 2B ). Additionally, we examined the AMPAR/NMDAR response ratio of evoked EPSCs (eEPSCs) and found that RA significantly increased the AMPAR/NMDAR ratio ( Figure 2C ) (DMSO, 1.12 ± 0.12; RA, 1.63 ± 0.17). We did not observe any effect of RA on the paired-pulse ratio or passive membrane properties ( Figures S2B and S2C ). Thus, RA selectively enhances AMPARmediated synaptic responses due to specific promotion of AMPAR insertion .
AMPAR insertion during LTP requires activity and NMDAR activation (Collingridge et al., 1983; Huganir and Nicoll, 2013) . Next, we asked whether the RA-mediated increase in the synaptic content of AMPARs also required activity and NMDAR activation. During acute RA treatment, we co-applied hippocampal slices with the voltage-gated sodium channel blocker tetrodotoxin (TTX) to block neuronal activity. Surprisingly, TTX coapplied with RA (<4 hr) blocked the enhancement of the mEPSC amplitude by RA ( Figure 2D ) (DMSO, 10.58 ± 0.30 pA; RA, 12.65 ± 0.24 pA; RA + TTX, 11.24 ± 0.31 pA). Note that this protocol differs from the TTX treatment used to induce homeostatic plasticity that involves a chronic pretreatment of neurons, not an (legend continued on next page) acute addition of TTX. To address whether NMDAR activity was also required for AMPAR insertion, in a manner similar to LTP, we co-applied APV acutely with RA (<4 hr) to specifically block NMDAR activation and found that this treatment also blocked the increase in mEPSC amplitude by RA ( Figure 2D ) (DMSO, 11.17 ± 0.28 pA; RA, 13.81 ± 0.51 pA; RA + APV, 11.31 ± 0.35 pA). Thus, similar to LTP-induced postsynaptic AMPAR insertion, the RA-mediated increase in post-synaptic AMPARs also requires NMDAR activation. In other words, RA only enhances the strength of actively used synapses, possibly as a mechanism to ensure that the RA-mediated AMPAR insertion does not occur at synapses that are not being used.
RA Activates Silent Synapses by Promoting AMPAR Insertion LTP induction is known to not only increase the abundance of AMPARs at synapses that already contain AMPARs but also activate ''silent'' synapses lacking AMPARs (but containing NMDARs) by inserting AMPARs into these synapses (Isaac et al., 1995; Liao et al., 1995) . Given the similar requirement of NMDAR activation for both LTP-induced and RA-induced AMPAR insertion at synapses, we were curious as to whether RA is capable of activating silent synapses by promoting insertion of AMPARs into NMDAR-only synapses. To induce formation of silent synapses, we applied a protocol used previously in cultured hippocampal slices-prolonged silencing of neural network activity with TTX for 60 hr-that reliably induces formation of silent synapses containing only NMDARs (Arendt et al., 2013 ) ( Figure 3A ). For the detection of silent synapses, cells were clamped at their resting membrane potential ($À60 mV), and excitatory synaptic transmission was elicited with a weak stimulus that produced failures in about 50% of trials. Epochs of 50 trials of transmission were recorded at À60 mV and +40 mV for each cell, and the failure rate at each of these two holding potentials was computed. In slices cultured under control conditions, the failure rate was comparable between the negative and the positive holding potentials ( Figures 3B and 3E ) (À60 mV, 55.73% ± 2.59%; +40 mV, 53.82% ± 3.83%), indicating that most synapses are active and contained both AMPARs and NMDARs at this stage of development. Consistent with previous work (Arendt et al., 2013) , prolonged TTX treatment induced formation of silent synapses, indicated by the significantly higher failure rate at À60 mV than at the +40 mV holding potential ( Figures  3C and 3E ) (À60 mV, 49.29% ± 2.28%; +40 mV, 20.61% ± 2.74%), which suggests that a larger proportion of synapses contain only NMDARs but not AMPARs. It is important to note that acute RA treatment, per se, did not induce silent synapses ( Figures 3D and 3E ) (À60 mV, 49.18% ± 3.76%; +40 mV, 48.57% ± 5.10%).
We then applied RA to slices that had been treated with TTX for 60 hr. Washing out TTX during RA treatment to restore network activity converted silent synapses to active synapses, as evidenced by the similar failure rates at À60 mV and +40 mV ( Figure 3F ) (60-hr TTX with wash + RA: À60 mV, 50.05% ± 2.38%; +40 mV, 48.82% ± 3.71%). This conversion of silent to functional synapses by RA requires intact network activity as well as NMDAR activation because the presence of TTX or APV during RA treatment prevented the activation of silent synapses ( Figure 3F ) (60-hr TTX with no wash + RA: À60 mV, 49.16% ± 4.12%; +40 mV, 26.76% ± 3.25%; 60-hr TTX with wash + RA + APV: À60 mV, 52.80% ± 4.30%; +40 mV, 28.51% ± 4.87%). It is important to note that simply washing out TTX without RA treatment was not sufficient to convert silent synapses into active synapses within the 4-hr time window used for our experiments ( Figure 3F ) (60-hr TTX with wash: À60 mV, 54.22% ± 4.00%; +40 mV, 31.68% ± 3.60%).
In addition to evoked EPSCs, we also examined mEPSCs during silent-synapse activation. As expected, homeostatic synaptic plasticity induced by prolonged TTX treatment manifested as an increase in mEPSC amplitude ( Figure 3G ) (DMSO, 11.58 ± 0.27 pA; 60-hr TTX, 14.06 ± 0.62 pA) without changes in mEPSC frequency ( Figure 3G ) (DMSO, 0.43 ± 0.05 Hz; 60-hr TTX, 0.37 ± 0.05 Hz) (Turrigiano et al., 1998) . By contrast, following prolonged TTX treatment, incubation with RA (in the absence of TTX) activated silent synapses, as evidenced by a significant increase in the mEPSC frequency ( Figure 3G ) (60-hr TTX with wash + RA, 0.66 ± 0.07 Hz). Notably, RA treatment after prolonged TTX treatment also decreased the mEPSC amplitude ( Figure 3G ) (60-hr TTX with wash + RA, 12.06 ± 0.54 pA), presumably because newly activated silent synapses have smaller mEPSC amplitudes. Thus, we plotted ranked amplitudes of the three groups ( Figure S3A ). Indeed, while prolonged TTX treatment induced synaptic scaling, responses recorded in neurons that received RA after TTX treatments displayed a large population of small amplitudes that are not apparently potentiated, likely representing the population of newly activated silent synapses ( Figure S3A ). Similar to the failure rate experiments described earlier, the presence of TTX during RA treatment prevented the activation of silent synapses, as evidenced by a lack of change in mEPSC frequency ( Figure 3H ) (amplitude: DMSO, 10.93 ± 0.25 pA; 60-hr TTX, 13.70 ± 0.41 pA; 60-hr TTX with no wash + RA, 12.66 ± 0.51 pA; frequency: DMSO, 0.37 ± 0.04 Hz; 60-hr TTX, 0.42 ± 0.05 Hz; 60-hr TTX with no wash + RA, 0.34 ± 0.07 Hz). Ranked plots of the mEPSC amplitudes confirmed this notion in that the TTX and the TTX with no wash + RA groups showed a similar degree of potentiation of mEPSC amplitudes ( Figure S3B ). Moreover, we previously showed that generation of silent synapses by prolonged TTX treatment leads to a greater (F) Failure rate of eEPSCs recorded at À60 mV and +40 mV from neurons treated with TTX plus wash/RA, TTX with no wash/RA, TTX with wash, and TTX with wash/RA + APV (***p < 0.0005). (G) Top: example traces of mEPSC recordings. Bottom: quantification of amplitude and frequency of mEPSCs recorded from CA1 pyramidal neurons treated with DMSO, TTX, and TTX with wash/RA (**p < 0.01; ***p < 0.001). Scale bars, 15 pA, 1 s. (H) Top: example traces of mEPSC recordings. Bottom: quantification of amplitude and frequency of mEPSCs recorded from CA1 pyramidal neurons treated with DMSO, TTX and TTX with no wash/RA (**p < 0.01; ***p < 1 3 10 À6 ). Scale bars, 15 pA, 1 s.
All graphs represent average values ± SEM.
potentiation when LTP is induced subsequently (Arendt et al., 2013) . This enhancement of LTP was completely reversed to an impairment of LTP if the slices were incubated with RA after TTX washout ( Figures S3C and S3D ) (control, 224.21% ± 30.24%; 60-hr TTX, 406.67% ± 44.38%; 60-hr TTX with wash + RA, 142.64% ± 17.21%), which is consistent with RA's action in converting silent synapses into functional synapses. By contrast, if RA was applied without TTX washout, the greater LTP was maintained ( Figures S3C and S3D ) (60-hr TTX with no wash + RA, 425.93% ± 73.96%). Taken together, the results obtained with both miniature and evoked synaptic responses strongly suggest that RA-induced AMPAR insertion into synapses shares common features with LTP-induced AMPAR insertion, in that both processes require neuronal activity and NMDAR activation. Although this finding may appear at first glance to be counterintuitive, given that RA-dependent homeostatic plasticity is induced by the inactivation of synaptic activity, not by increased synaptic activity, it is remarkable that expression of homeostatic plasticity nevertheless requires a suspension of chronic inactivity-continuous blockade of synaptic activity in fact prevents homeostatic plasticity.
Postsynaptic Cpx Is Not Required for RA-Mediated AMPAR Delivery to the Synapse Intrigued by the common requirement of NMDAR activation for AMPAR insertion in the LTP and RA pathways, we sought to further dissect the steps downstream of NMDAR activation in RA-induced AMPAR insertion. Similar to presynaptic neurotransmitter vesicle release, postsynaptic vesicle exocytosis is thought to involve assembly of SNARE complexes and SNARE-binding proteins. Indeed, Cpx, an important co-factor for synaptotagmin-triggered presynaptic vesicle fusion (McMahon et al., 1995; Reim et al., 2001) , is required for the activityregulated exocytosis of postsynaptic AMPAR-containing vesicles during LTP, but not for constitutive AMPAR insertion (Ahmad et al., 2012) . Therefore, we investigated the involvement of Cpx in the RA-induced increase of excitatory synaptic transmission using an shRNA-mediated knockdown (KD) of Cpx (Ahmad et al., 2012; Maximov et al., 2009 ). Specifically, a multi-promoter lentivirus encoding two shRNAs targeting both Cpx1 and Cpx2 was injected into the CA1 pyramidal cell layer of cultured hippocampal slices to knock down postsynaptic Cpx. We found that, consistent with previous observations (Ahmad et al., 2012) , postsynaptic Cpx was not required for maintaining basal synaptic transmission ( Figure 4A ) (mEPSC amplitude: control, 11.04 ± 0.38 pA; Cpx KD, 10.23 ± 0.30 pA). Notably, acute RA treatment significantly increased the mEPSC amplitude in both control and neighboring Cpx KD neurons (Figure 4A ) (mEPSC amplitude in RA: control, 12.81 ± 0.35 pA; Cpx KD, 12.77 ± 0.40 pA). Thus, unlike the LTP pathway, RA-induced AMPAR delivery to the synapse does not require Cpx.
Postsynaptic Syb-2 and SNAP-47 Are Both Required for RA-Mediated AMPAR Delivery to the Synapse Previous studies using postsynaptic loading of the light chains of botulinum toxin B or tetanus toxin (which cleave the R-SNARE Syb-2) (Link et al., 1992; Schiavo et al., 1992 ) and, more recently, studies using Syb-2 KO mice and postsynaptic rescue have suggested that this R-SNARE protein is critical for the delivery of AMPARs to the plasma membrane during LTP (Jurado et al., 2013; Lledo et al., 1998) . To examine the involvement of Syb-2 in RA-mediated AMPAR synaptic delivery, we injected a lentivirus expressing tetanus toxin light chain (tetTox) (Xu et al., 2012) into postsynaptic CA1 neurons in cultured hippocampal slices. RA strongly increased the mEPSC amplitude in neighboring uninfected neurons ( Figure 4B ) (mEPSC amplitude: DMSO, 9.99 ± 0.29 pA; RA, 12.88 ± 0.46 pA) but had no effect on tetTox-expressing neurons ( Figure 4B ) (mEPSC amplitude: DMSO, 11.45 ± 0.49 pA; RA, 10.86 ± 0.34 pA), indicating a critical involvement of postsynaptic Syb-2 in RA-induced AMPAR exocytosis.
Two target Q-SNAREs-syntaxins and SNAP-25 or its homologs-are involved in vesicle exocytosis. Presynaptically, SNAP-25 is specifically required for neurotransmitter release (Sü dhof and Rothman, 2009); postsynaptically, SNAP-25 is essential for normal surface expression of NMDARs (Jurado et al., 2013; Lau et al., 2010) . However, for activity-dependent surface delivery of AMPARs during LTP, SNAP-47, but not SNAP-25, is critical (Jurado et al., 2013) . Therefore, we examined the involvement of SNAP-47 in RA-mediated AMPAR insertion using the same shRNA lentiviral constructs that were previously characterized (Jurado et al., 2013) . Postsynaptic KD of SNAP-47 completely abolished the RA-induced increase in mEPSC amplitude ( Figure 4C ) (SNAP-47 KD: DMSO, 10.83 ± 0.43 pA; RA, 11.10 ± 0.40 pA), whereas neighboring uninfected neurons responded robustly to RA treatment ( Figure 4C ) (DMSO, 10.89 ± 0.30 pA; RA, 13.28 ± 0.45 pA). The deficits observed in the SNAP-47 KD neurons were fully rescued by simultaneous expression of an shRNA-resistant wild-type SNAP-47 (SNAP-47 Rep; Figure 4D ) (control/DMSO, 10.52 ± 0.22 pA; control/RA, 12.72 ± 0.50 pA; SNAP-47 Rep/DMSO, 10.32 ± 0.20 pA; SNAP-47 Rep/RA, 12.00 ± 0.29 pA). Thus, both LTP-and RA-induced exocytosis of AMPAR-containing vesicles requires the R-SNARE Syb-2 and the Q-SNARE SNAP-47.
Postsynaptic Syntaxin-4, but Not Stx-3, Is Required for RA-Mediated Synaptic Delivery of AMPARs Next, we focused on syntaxin Q-SNAREs. Syntaxins contain a conserved N-terminal peptide that binds to Sec1/Munc18-like proteins (SM proteins), followed by an Habc domain, a SNARE motif, and a carboxyl-terminal (C-terminal) transmembrane region ( Figure 5A ). We systematically examined Stx-1, Stx-3, and syntaxin-4 (Stx-4) because all of these isoforms are highly expressed in neurons but seem to mediate distinct types of vesicle fusion. Stx-1 forms the SNARE complex with Syb-2 and SNAP-25 that mediates transmitter release (Sü dhof and Rothman, 2009) but is not required for postsynaptic constitutive AMPAR exocytosis during basal synaptic transmission or for regulated AMPAR insertion induced by LTP (Jurado et al., 2013) . We found that, similar to these previous observations, the postsynaptic Stx-1 KD had no effect on the basal mEPSC amplitude or on the RA-mediated increase in mEPSC amplitude ( Figure 5A KD/RA, 12.13 ± 0.40 pA). Stx-3, like Stx-1, binds Cpx via a specific 12-amino-acid stretch within the SNARE motif (Figures 5A and 5B; Pabst et al., 2000) but differs from Stx-1 in that Stx-3 is required for AMPAR exocytosis during LTP, whereas Stx-1 is not (Jurado et al., 2013) . We confirmed that the Stx-3 KD had no effect on basal synaptic transmission, but we were surprised to find that the Stx-3 KD did not block the RA-induced increase in postsynaptic AMPAR responses, which is different from its effect on LTP ( Figure 5B ) (mEPSC amplitudes: control/DMSO, 10.24 ± 0.21 pA; control/RA, 12.04 ± 0.43 pA; Stx-3 KD/DMSO, 10.36 ± 0.36 pA; Stx-3 KD/RA, 12.33 ± 0.60 pA). In stark contrast, the Stx-4 KD completely abolished the RA-induced enhancement of AMPAR-mediated responses without affecting basal transmission ( Figure 5C ) (control/DMSO, 10.63 ± 0.21 pA; control/RA, 13.39 ± 0.39 pA; Stx-4 KD/DMSO, 10.25 ± 0.28 pA; Stx-4 KD/RA, 10.64 ± 0.17 pA).
It is interesting that Stx-4 was previously shown to mediate insulin-dependent glucose transport through regulation of membrane GLUT4 trafficking (Dugani and Klip, 2005; Olson et al., 1997) . Moreover, a study using hippocampal primary cultures proposed that Stx-4 is critically involved in the activity-dependent exocytosis of a transferrin-EGFP fusion protein that is used as a proxy for AMPARs in dendritic spines and thus suggested that Stx-4 plays a role in AMPAR trafficking in LTP (Kennedy et al., 2010) . A more direct investigation of syntaxins in LTP using acute hippocampal slices, however, showed that it was Stx-3, not Stx-4, that mediates AMPAR-containing vesicle exocytosis in LTP (Jurado et al., 2013 ). Since we now, using a different preparation (cultured hippocampal slices), suggest that Stx-4 is critical for RA-triggered AMPAR exocytosis, we were concerned that differences between previous studies may have been due to differences in the experimental approach instead of true differences in biological processes. To address this concern, we repeated the LTP experiments with syntaxin KD in our cultured hippocampal slices, with the aim to directly compare the apparently distinct roles of Stx-3 and Stx-4 in two different types of plasticity in the same preparation. We found that, as with acute slices (Jurado et al., 2013) , Stx-3, but not Stx-4, was essential for hippocampal LTP ( Figures 5D  and 5E ) (control, 264.63% ± 24.13%; Stx-3 KD, 142.55% ± 23.55%; Stx-4 KD, 260.35% ± 48.76%). Taken together, these results suggest the intriguing possibility that RA-induced AMPAR exocytosis is mediated by a novel activity-dependent trafficking pathway that is mechanistically distinct from the LTP pathway or from the constitutive ANPAR exocytosis pathway. While the LTP-and RA-induced AMPAR exocytosis pathways share two SNARE proteins, Syb-2 and SNAP-47, they utilize distinct syntaxins, which may play a role in defining these distinct pathways.
Cpx-Binding Sequence of Stx-3 Blocks RA-Mediated Synaptic Delivery of AMPARs Stx-1 and Stx-3 contain a Cpx-binding sequence in the SNARE motif, whereas Stx-4 does not (Figures 5A-5C ; Pabst et al., 2000) . Cpx binding to Stx-1 and Stx-3 is required for their respective functions in neurotransmitter release and LTP (Jurado et al., 2013; Sü dhof and Rothman, 2009). Although we have shown that Cpx is not required for RA-mediated AMPAR delivery to the synapse, we were curious as to whether Stx-4's inability to bind Cpx is important for its function in RAmediated AMPAR insertion. We addressed this question by swapping the Cpx-binding sequence of Stx-3 (amino acids 213-224) with the homologous sequence of Stx-4 that does not interact with Cpx, resulting in two chimeric proteins: a Stx-4 that now binds Cpx (Stx-4/3) and a Stx-3 that no longer binds Cpx (Stx-3/4 ). Then, we tested the ability of these two chimeras to rescue the effect of the Stx-4 KD on RA-induced AMPAR insertion. In contrast to a shRNA-resistant wild-type Stx-4 rescue construct (Stx-4 Rep), which fully rescued the effect of RA on AMPAR-mediated synaptic transmission (Figure 6A ) (control/DMSO, 10.25 ± 0.22 pA; control/RA, 12.23 ± 0.23 pA; Stx-4 Rep/DMSO, 10.36 ± 0.33 pA; Stx-4 Rep/RA, 11.88 ± 0.26 pA), mutant Stx-4/3 failed to restore the RAinduced increase in AMPAR mEPSC amplitude ( Figure 6B ) (control/DMSO, 10.65 ± 0.21 pA; control/RA, 12.48 ± 0.36 pA; Stx-4/3 rescue constructs (Stx-4/3 Rep)/DMSO, 11.06 ± 0.25 pA; Stx-4/3 Rep/RA, 10.22 ± 0.30 pA). This result indicates that lack of Cpx binding is, indeed, an important functional feature of Stx-4 for its role in mediating RA-induced, activityregulated AMPAR insertion. We also tested the reverse chimera, Stx-3/4, where the Stx-3 Cpx-binding sequence is replaced by the homologous sequence in Stx-4 that does not interact with Cpx. This rescue construct also failed to reverse the Stx-4 KD phenotype; RA was still unable to increase mEPSCs amplitude in neurons expressing this chimera ( Figure 6C ) (control/DMSO, 10.37 ± 0.40 pA; control/RA, 12.89 ± 0.52 pA; Stx-3/4 rescue constructs (Stx-3/4 Rep)/DMSO, 10.43 ± 0.41 pA; Stx-3/4 Rep/RA, 10.42 ± 0.26 pA). Thus, additional Stx-4-specific functional sequence motifs besides the absence of Cpx-binding sequence are required for the RA-mediated, activity-dependent synaptic delivery of AMPARs.
Blocking Stx-4-Mediated AMPAR Synaptic Delivery Rescues LTP after RA Treatment Our molecular dissection of the AMPAR exocytosis mechanisms revealed a novel AMPAR insertion pathway that is regulated by synaptic activity. However, it remains undetermined how RA treatment blocks subsequent development of LTP (see Figure 1) . One possibility is that, because the RA and LTP pathways converge onto the same final common step-an increase in AMPAR content at synapses-these two processes occlude each other either because of depletion of the AMPARs in the reserve pool or because of the filling of the synaptic slots that are required for receiving AMPARs at synapses. If one of these hypotheses is correct, selectively preventing RA-induced AMPAR exocytosis, but not LTP-induced AMPAR exocytosis, should rescue the block of LTP by RA. However, it is also possible that RA has additional unknown effects in a neuron that somehow compromise LTP signaling pathways upstream to AMPAR insertion. If this were the case, preventing AMPAR insertion during RA treatment should not rescue LTP. We directly tested this possibility by examining LTP in Stx-4 KD neurons that were treated with RA. Both DMSO-and RA-treated neurons receiving Stx-4 KD expressed normal LTP ( Figures 7A  and 7B ) (Stx-4 KD/DMSO, 349.17% ± 43.90%; Stx-4 KD/RA, 421.29% ± 79.01%). Thus, RA treatment impairs subsequent LTP induction through its effect on the step of AMPAR synaptic delivery.
DISCUSSION
The connectivity of a neural network can be modified by at least two major forms of long-lasting plasticity: Hebbian and homeostatic plasticity. Although operating under opposite computational mechanisms (positive feedback mechanisms for Hebbian plasticity versus negative feedback mechanisms for homeostatic plasticity), these two types of plasticity likely interact at multiple points at the biochemical, molecular, and structural levels, altering parameters such as neuronal excitability through modulation of expression levels of ion channels (Campanac and Debanne, 2007; Magee and Johnston, 2005) , synaptic strength through modulation of release probability and postsynaptic receptor abundance (Davis and Muller, 2015; Grasselli and Hansel, 2014; Huganir and Nicoll, 2013) , and-at a longer timescale-number of synaptic contacts through modulation of synapse formation and elimination (Bourne and Harris, 2008; Sala and Segal, 2014; Yu and Zuo, 2011) . In the present study, we dissected the AMPAR trafficking mechanisms involved in RA-dependent homeostatic plasticity and compared these mechanisms to those involved in LTP. Moreover, we examined the intersection of the mechanisms mediating RA-and LTP-induced AMPAR-trafficking and focused on the interaction between synaptic RA signaling and LTP.
We found that increasing excitatory synaptic strength through synaptic RA signaling impaired subsequent induction of LTP at hippocampal synapses through a mechanism that is mediated by the RA receptor RARa and requires protein synthesis. In further exploring the molecular mechanism of such interaction, we made two unexpected discoveries. First, although RA synthesis in neurons seems to be triggered by reduced synaptic activity (Wang et al., 2011) , RA-induced insertion of AMPARs into synapses, paradoxically, requires activity and NMDAR activation. Second, RA-induced exocytosis of AMPAR-containing vesicles requires a SNARE-dependent membranefusion machinery (Syb-2, SNAP-47, and Stx-4, but not Cpx) whose components only partially overlap with those involved in LTP-induced exocytosis of AMPAR-containing vesicles (Syb-2, SNAP-47, and Stx-3, with Cpx), thus revealing a novel activity-regulated AMPAR trafficking pathway that is distinct from the LTP pathway.
AMPAR Trafficking in RA-and LTP-Induced Synaptic Potentiation Requires Distinct SNARE-Dependent Vesicle Fusion Machineries
The speed and precision required for presynaptic neurotransmitter release makes it an attractive system for studying vesicle fusion and deciphering the regulatory mechanisms that gate the fusion event. Indeed, we have a reasonably good understanding of the molecular players required for Ca 2+ -regulated exocytosis of synaptic vesicles (Rizo and Rosenmund, 2008; Sü dhof, 2013; Sü dhof and Rothman, 2009 ). However, although it has been long accepted that Ca 2+ is also a key element in the regulation of biochemical processes in postsynaptic compartments, and that activity-regulated postsynaptic exocytosis likely requires SNAREs and SNARE-binding proteins, we are just beginning to identify individual components required for various postsynaptic vesicle exocytosis events. For example, Cpx plays multiple roles in neurotransmitter release, including vesicle priming (Yang et al., 2010) , activation of SNARE complexes before vesicle fusion (Maximov et al., 2009; Reim et al., 2001; Xue et al., 2009) , and clamping of SNARE complexes to prevent inappropriate fusion (Giraudo et al., 2006; Huntwork and Littleton, 2007; Maximov et al., 2009; Tang et al., 2006; Xue et al., 2009; Yang et al., 2010) . The role of Cpx in postsynaptic AMPAR-containing vesicle exocytosis during LTP was recently documented and is thought to function by binding to the Q-SNARE Stx-3 instead of Stx-1 (Ahmad et al., 2012) , thus expanding the repertoire of Cpx functions to postsynaptic vesicular trafficking. Notably, for RA-mediated AMPAR trafficking during non-Hebbian plasticity, not only is Cpx binding unnecessary, but it may also ''clamp'' the fusion event and prevent it from occurring when a Cpx-binding sequence is introduced into Stx-4 (Figure 6B) . These results raise the possibility that Cpx binding might help define a subpopulation of postsynaptic AMPAR-containing vesicles that is exclusively involved in LTP but not in homeostatic or other activity-dependent forms of plasticity. This notion is supported, in part, by our observation that the non-Cpx-binding Stx-4 is selectively required for RA-induced AMPAR insertion, instead of Stx-3, which is required for LTP, or Stx-1, which is required for presynaptic vesicle fusion. Thus, one attractive model for the differential regulation of postsynaptic activity-regulated AMPAR exocytosis is that Stx-3 and Stx-4 define separate vesicle fusion sites on the target plasma membrane for insertion of AMPAR-containing vesicles. During LTP, AMPAR-containing vesicles associate with Cpx, and they dock and exocytose at Stx-3-rich membrane sites, whereas during synaptic RA signaling, non-Cpx-associated AMPAR-containing vesicles dock and exocytose at Stx-4-rich membrane sites (Figure 8 ). Despite the mechanistic similarities between pre-and postsynaptic SNARE-mediated vesicle exocytosis, these processes exhibit important differences that involve distinct molecular mechanisms, possibly for the purpose of differentially regulating these processes. To support presynaptic transmitter release, which is triggered rapidly (<1 ms) by calcium at the active zone, intricate presynaptic scaffold structures are required for docking and priming of synaptic vesicles (Sü dhof, 2013) . By contrast, ultrastructural studies failed to observe docked AMPAR-containing vesicles on the postsynaptic membranes, either because postsynaptic fusion events are much less frequent than those that occur at presynaptic site or because calcium-triggered postsynaptic vesicle exocytosis during LTP may occur at a slower time course (Makino and Malinow, 2009; Patterson et al., 2010; Petrini et al., 2009; Yudowski et al., 2007) . Findings from the present study add another level of complexity to the picture by revealing a second form of activity-regulated, AMPAR-containing vesicle exocytosis, mediated by a different syntaxin than that used by the LTP pathway. Additionally, SNAP-47, the other Q-SNARE required for both postsynaptic vesicle exocytosis processes, may be partly soluble compared to the permanently membrane-localized SNAP-25 at the presynaptic side (Holt et al., 2006) . Therefore, more work is required to determine whether postsynaptic vesicle exocytosis sites for the LTP and RA pathways are permanent or transient.
How does RA-induced AMPAR insertion block subsequent development of LTP? One possibility is that the AMPAR-containing vesicle pool is a limiting factor. RA induces synaptic incorporation of GluA2-lacking AMPARs Maghsoodi et al., 2008; Wang et al., 2011) . Similarly, LTP has been proposed to induce the insertion of GluA2-lacking AMPARs (Guire et al., 2008; Morita et al., 2014; Plant et al., 2006 ; but see Adesnik and Nicoll, 2007; Gray et al., 2007) . Therefore, it is possible that the two processes share and compete for the same GluA2-lacking AMPAR vesicle pool. Local biochemical events specifically associated with each type of plasticity could direct these vesicles for fusion with a Cpx/Stx-3-dependent mechanism for the LTP pathway or fusion with a Cpx-independent, Stx-4-dependent mechanism for the RA pathway (Figure 8) . Alternatively, the AMPAR vesicles used for each pathway may differ. Instead, the synaptic ''slots'' available for stabilizing newly inserted AMPARs could be limiting. It is, then, possible that RAinduced AMPAR insertion into synapses occupies these slots and prevents subsequent LTP (Figure 8 ). Further experiments are required to distinguish between these two possibilities.
Activity Dependence of RA-Mediated AMPAR Trafficking An intriguing finding in the present study is the requirement of neuronal activity and NMDAR activation for RA-induced AMPAR insertion-a process that has much similarity with the LTP pathway, except in the molecular constituents of the fusion machinery. The function of RA in synaptic signaling was discovered in the context of homeostatic synaptic plasticity, namely, the synaptic-inactivity-induced upregulation of synaptic strength Wang et al., 2011) . RA synthesis is triggered by reduced dendritic Ca 2+ (Wang et al., 2011) . Here, our findings suggest that, once RA is made and synthesis of new AMPARs is activated by RA, AMPAR incorporation into the existing synapses is not merely a default step. Instead, activity and NMDAR activation are required to execute the final step of receptor localization to the synapse. Thus, homeostatic synaptic plasticity, at least the form that is mediated by RA signaling, seems to require two major regulatory steps. The first step is the prolonged-inactivity-triggered RA production and AMPAR synthesis, a step that ''primes'' the postsynaptic neurons for rapid strengthening of excitatory synapses. However, AMPARs are not ''blindly'' inserted into all existing excitatory synapses. The second step is an execution step that inserts AMPARs to functional synapses via a validation process-brief activation of the synapse (mediated by NMDAR activation and a transient postsynaptic Ca 2+ rise) that is indicative of a functional synapse. The execution step ensures insertion of AMPARs into synapses that are part of a functional circuit. What might be the advantage of having such an additional synaptic function ''checkpoint'' for homeostatic synaptic plasticity? Conceptually, the role of homeostatic plasticity in a neural network is to compensate for prolonged changes in the input activity that deviates from its optimal range (too high or too low). In the case of prolonged reduction in input activity, inputs that are experiencing reduced upstream activity (thus representing weaker, but still functional, input) and those that are experiencing permanent loss of input activity (thus destined to be eliminated) can both contribute to the activation of homeostatic compensation mechanisms (i.e., RA synthesis). As such, it is, perhaps, most effective if compensation through an increase in postsynaptic receptor number occurs at synapses where active presynaptic release still occurs (albeit, at a reduced level), as opposed to synaptic contacts that are destined to be removed. A validation step using NMDAR activity acts as an ideal switch to permit activity-regulated exocytosis of AMPAR-containing vesicles at functional synapses. Such selective strengthening of all functional connections renormalizes the synaptic strength of a network to allow readjustment of an optimal dynamic range of activity for all meaningful connections while leaving the nonfunctional ones out. Furthermore, this validation process might, in fact, support the phenomenon of ''synaptic scaling,'' in which synapses of different sizes increase their strength in a multiplicative fashion during homeostatic upregulation, as previously proposed based on observations in cultured cortical neuron networks (Turrigiano et al., 1998) . If the AMPAR insertion into functional synapses is regulated by local synaptic activity (and, presumably, local Ca 2+ influx) , it is conceivable that bigger synapses with more NMDARs can potentially gain more new AMPARs than smaller ones, thus providing a biochemical mechanism for synaptic scaling.
In summary, our findings suggest that the functional impact of RA at synapses goes beyond homeostatic plasticity and that, despite the divergence in the molecular mechanisms underlying Hebbian and homeostatic plasticity, these two major forms of synaptic plasticity interact functionally (Arendt et al., 2013; Toyoizumi et al., 2014) . Additionally, the findings presented here provide concrete molecular tools that can be used for future work to investigate the function of synaptic RA signaling and homeostatic synaptic plasticity in vivo in the context of animal learning.
EXPERIMENTAL PROCEDURES
The RARa floxed mouse is a gift from Drs. Pierre Chambon and Norbert Ghyselinck (IGBMC, Strasbourg, France) (Chapellier et al., 2002) . Breeding colonies are maintained in the animal facility at Stanford Medical School following standard procedures approved by the Stanford University Administrative Panel on Laboratory Animal Care. Organotypic slice cultures were prepared from RARa floxed mice (postnatal days 6-7) and maintained for 5-7 days prior to recording Arendt et al., 2013) .
Full experimental procedures and associated references are available in the Supplemental Information.
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